Risk assessment of effects of cadmium on human health (IUPAC Technical Report)
Open accessThe DOI matches its Crossref record; 175 of the 175 references it cites were found in a registry or an index.
Abstract
Chemistry and Human Health, Division VII of the International Union on Pure and Applied Chemistry (IUPAC), provides guidance on risk assessment methodology and, as appropriate, assessment of risks to human health from chemicals of exceptional toxicity. The aim of this document is to describe dose-response relationships for the health effects of low-level exposure to cadmium, in particular, with an emphasis on causation. The term “cadmium” in this document includes all chemical species of cadmium, as well as those in cadmium compounds. Diet is the main source of cadmium exposure in the general population. Smokers and workers in cadmium industries have additional exposure. Adverse effects have been shown in populations with high industrial or environmental exposures. Epidemiological studies in general populations have also reported statistically significant associations with a number of adverse health effects at low exposures. Cadmium is recognized as a human carcinogen, a classification mainly based on occupational studies of lung cancer. Other cancers have been reported, but dose-response relationships cannot be defined. Cardiovascular disease has been associated with cadmium exposure in recent epidemiological studies, but more evidence is needed in order to establish causality. Adequate evidence of dose-response relationships is available for kidney effects. There is a relationship between cadmium exposure and kidney effects in terms of low molecular mass (LMM) proteinuria. Long-term cadmium exposures with urine cadmium of 2 nmol mmol−1 creatinine cause such effects in a susceptible part of the population. Higher exposures result in increases in the size of these effects. This assessment is supported by toxicokinetic and toxicodynamic (TKTD) modelling. Associations between urine cadmium lower than 2 nmol mmol−1 creatinine and LMM proteinuria are influenced by confounding by co-excretion of cadmium with protein. A number of epidemiological studies, including some on low exposures, have reported statistically significant associations between cadmium exposure and bone demineralization and fracture risk. Exposures leading to urine cadmium of 5 nmol mmol−1 creatinine and more increase the risk of bone effects. Similar associations at much lower urine cadmium levels have been reported. However, complexities in the cause and effect relationship mean that a no-effect level cannot be defined. LMM proteinuria was selected as the critical effect for cadmium, thus identifying the kidney cortex as the critical organ, although bone effects may occur at exposure levels similar to those giving rise to kidney effects. To avoid these effects, population exposures should not exceed that resulting in cadmium values in urine of more than 2 nmol mmol−1 creatinine. As cadmium is carcinogenic, a ‘safe’ exposure level cannot be defined. We therefore recommend that cadmium exposures be kept as low as possible. Because the safety margin for toxic effects in kidney and bone is small, or non-existent, in many populations around the world, there is a need to reduce cadmium pollution globally.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoporosis Prevention, Diagnosis, and Therapy
NIH Consensus Development Panel on Osteoporosis Prevention, D. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.6.785 · Cited by 5,529
Marshall, D., Johnell, O., & Wedel, H. (1996) · BMJ · doi:10.1136/bmj.312.7041.1254 · Cited by 3,709
Current status of cadmium as an environmental health problem
Järup, L., & Åkesson, A. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.04.020 · Cited by 2,355
Barr, D. B., Wilder, L. C., Caudill, S. P., Gonzalez, A. J., Needham, L. L., & Pirkle, J. L. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7337 · Cited by 1,921
Human Respiratory Tract Model for Radiological Protection
Icrp (1994) · Annals of the ICRP · Cited by 1,767
IARC (International Agency for Research on Cancer)
Toporcov, T. N., & Filho, V. W. (2018) · Cited by 1,178
Glossary of terms used in toxicology, 2nd edition (IUPAC Recommendations 2007)
Duffus, J. H., Nordberg, M., & Templeton, D. M. (2007) · Pure and Applied Chemistry · doi:10.1351/pac200779071153 · Cited by 787
Self-citationInterim Report and Recommendations of the World Health Organization Task-Force for Osteoporosis
Genant, H. K., Cooper, C., Poor, G., Reid, I., Ehrlich, G., Kanis, J., Nordin, B. E. C., Barrett-Connor, E., Black, D., Bonjour, J.-P., et al. (1999) · Osteoporosis International · doi:10.1007/s001980050224 · Cited by 783
Coordination Dynamics of Zinc in Proteins
Maret, W., & Li, Y. (2009) · Chemical Reviews · doi:10.1021/cr800556u · Cited by 644
Environmental exposure to cadmium and risk of cancer: a prospective population-based study
Nawrot, T., Plusquin, M., Hogervorst, J., Roels, H. A., Celis, H., Thijs, L., Vangronsveld, J., Van Hecke, E., & Staessen, J. A. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70545-9 · Cited by 624
Cited by
Metallothionein and Cadmium Toxicology—Historical Review and Commentary
Nordberg, M., & Nordberg, G. F. (2022) · Biomolecules · doi:10.3390/biom12030360 · Cited by 231
“Cd binds to MTs in all tissues (Section 2) and adverse effects in lungs, the skeleton, liver and kidneys as well as cancer [3,19] are likely to be modified by binding to metallothioneins.”
BackgroundInfluentialSelf-citationLiu, P., Rao, D., Zou, L., Teng, Y., & Yu, H. (2021) · Science of The Total Environment · doi:10.1016/j.scitotenv.2021.145447 · Cited by 161
Metadata
- Authors
- Nordberg, G. F., Bernard, A., Diamond, G. L., Duffus, J. H., Illing, P., Nordberg, M., Bergdahl, I. A., Jin, T., & Skerfving, S.
- Venue
- Pure and Applied Chemistry
- Publisher
- Walter de Gruyter GmbH
- Published
- 2018-01-10
- Volume
- 90
- Issue
- 4
- Pages
- 755-808
- ISSN
- 0033-4545 (ISSN-L)
- 1365-3075
- OpenAlex
- W2782752338
- Cited by
- 222
- References
- 175
- FWCI
- 8.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.